T Cell Activation and Clonal Selection
Immune Response Against Viral Pathogens
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 19, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
Daniel L V Bader1, Claudia T Flynn2, Oleksandr Kalyuzhniy3
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Developing an HIV vaccine requires understanding broadly neutralizing antibodies (bnAbs). This study analyzes VH1-46 bnAbs, revealing diverse structures and identifying classes that can guide future vaccine design for optimal targeting.
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: